Traders sold shares of UnitedHealth Group Incorporated (NYSE:UNH) on strength during trading hours on Tuesday. $104.69 million flowed into the stock on the tick-up and $142.98 million flowed out of the stock on the tick-down, for a money net flow of $38.29 million out of the stock. Of all companies tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $2.35 for the day and closed at $212.60

Several research analysts have commented on the stock. Cowen and Company reissued an “outperform” rating and set a $220.00 price objective (up previously from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Morgan Stanley increased their price target on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. Oppenheimer Holdings, Inc. increased their price target on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a report on Wednesday, October 18th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $208.00 price target on shares of UnitedHealth Group in a report on Tuesday, October 17th. Three investment analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $216.65.

The company has a market capitalization of $206,023.75, a PE ratio of 22.15, a PEG ratio of 1.58 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm posted $2.17 earnings per share. analysts anticipate that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio is presently 33.26%.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of UnitedHealth Group stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the transaction, the insider now directly owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold 57,606 shares of company stock valued at $11,433,133 over the last 90 days. 0.89% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Blue Chip Partners Inc. purchased a new position in UnitedHealth Group in the second quarter valued at $110,000. Bruderman Asset Management LLC purchased a new position in UnitedHealth Group in the second quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its holdings in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares in the last quarter. BDO Wealth Advisors LLC purchased a new position in UnitedHealth Group in the second quarter valued at $121,000. Finally, Kings Point Capital Management increased its holdings in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares in the last quarter. 85.71% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This piece was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/11/23/investors-sell-shares-of-unitedhealth-group-incorporated-unh-on-strength-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.